Acorda Therapeutics Inc. (acor 6 12/01/24)
13F holders, Q1 2024 (March 31)1holders
$0.57avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Acorda Therapeutics Inc. (acor 6 12/01/24) in their 13F filings. The largest holder was Saltoro Capital, LP ($855K).
- Company
- Acorda Therapeutics Inc. (acor 6 12/01/24)
- CUSIP
- 00484MAC0
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Saltoro Capital, LP | 8.36% | No change | 1,500,000 | $855K |
"% of holder's portfolio" is ACORDA THERAPEUTICS INC (ACOR 6 12/01/24)'s weight in each manager's 13F, not the share of Acorda Therapeutics Inc. (acor 6 12/01/24) the manager owns.